Much More Is Needed, Industry Says In Response To EU's 19-Point Regulatory Action Plan
The new EU Medical Device and IVD Regulations are reaching a critical tipping point. The 19-point plan just released is not going to cut it, medtech players fear. Is this really the lifeline needed for the medtech industry?
You may also be interested in...
EU Medtech Industry Awaits Outcome Of MDCG’s Urgent Meeting With Bated Breath
Will the EU agree that Article 97 is the way to go to avoid notified body bottlenecks in the context of the Medical Device Regulation? This matter is now being reviewed at the highest levels.
French Government Will Tell Commission To Give Notified Bodies Time To Process All Files
Despite proposals to alleviate the threat of medtech products being unnecessarily removed from the EU market when their old certificates expire, concerns remain at the highest level and calls for action persist.
MDCG Listens To Industry Over New Medtech Regulation Hurdles And Publishes 19-Point Action Plan
The medtech sector will be relieved to see this latest document relating to the implementation of the EU’s Medical Device and IVD Regulation. Its concrete proposals address multiple concerns.